Efficacy of eculizumab in refractory life‐threatening warm autoimmune hemolytic anemia associated with chronic myelomonocytic leukemia.

Autor: Gauchy, Anne‐Cécile, Hentzien, Maxime, Wynckel, Alain, de Marcellus, Victoire, Rodier, Cyrielle, Delmer, Alain, Quinquenel, Anne
Předmět:
Zdroj: Clinical Case Reports; Dec2020, Vol. 8 Issue 12, p2641-2644, 4p
Abstrakt: Eculizumab may be considered as an emergency therapeutic option in refractory life‐threatening warm autoimmune hemolytic anemia especially if direct antiglobulin test is positive for both IgG and C3d and after failure of all conventional treatments. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index
Nepřihlášeným uživatelům se plný text nezobrazuje